Autolus Therapeutics (AUTL)

• Market cap: $327M
• 1 day: -3.15%
• 5 days: -2.38%
• 1 month: -27.65%
• 3 months: -28.9%
• 6 months: -19.61%
• Year to date: -53.23%
• 1 year: -56.07%
• 5 years: -88.71%
• 10 years: -95.08%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647